These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 2122675)

  • 1. Value of MR imaging in differentiating benign from malignant soft-tissue masses: study of 95 lesions.
    Berquist TH; Ehman RL; King BF; Hodgman CG; Ilstrup DM
    AJR Am J Roentgenol; 1990 Dec; 155(6):1251-5. PubMed ID: 2122675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR imaging of soft-tissue masses: diagnostic efficacy and value of distinguishing between benign and malignant lesions.
    Moulton JS; Blebea JS; Dunco DM; Braley SE; Bisset GS; Emery KH
    AJR Am J Roentgenol; 1995 May; 164(5):1191-9. PubMed ID: 7717231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of soft-tissue masses with MR imaging: can benign masses be differentiated from malignant ones?
    Crim JR; Seeger LL; Yao L; Chandnani V; Eckardt JJ
    Radiology; 1992 Nov; 185(2):581-6. PubMed ID: 1410377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of magnetic resonance imaging in the diagnosis of soft tissue lesions.
    Sharafuddin MJ; Sundaram M
    Crit Rev Diagn Imaging; 1994; 35(5):379-483. PubMed ID: 7832987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are signal intensity and homogeneity useful parameters for distinguishing between benign and malignant soft tissue masses on MR images? Objective evaluation by means of texture analysis.
    Mayerhoefer ME; Breitenseher M; Amann G; Dominkus M
    Magn Reson Imaging; 2008 Nov; 26(9):1316-22. PubMed ID: 18448302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soft-tissue masses: diagnosis using MR imaging.
    Kransdorf MJ; Jelinek JS; Moser RP; Utz JA; Brower AC; Hudson TM; Berrey BH
    AJR Am J Roentgenol; 1989 Sep; 153(3):541-7. PubMed ID: 2763953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benign and malignant soft tissue mass: magnetic resonance imaging criteria for discrimination.
    Kalayanarooj S
    J Med Assoc Thai; 2008 Jan; 91(1):74-81. PubMed ID: 18386548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The identification of the criteria of malignancy and the tissue characterization of expansive processes in periskeletal soft tissues. The current role of magnetic resonance].
    Cappabianca S; De Luca AM; Iscaro FM; Sirignano C; Cantarella R; Del Vecchio W; Grassi R
    Radiol Med; 1999 Sep; 98(3):127-32. PubMed ID: 10575440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of magnetic resonance imaging in the evaluation of the soft tissue mass.
    Tung GA; Davis LM
    Crit Rev Diagn Imaging; 1993; 34(5):239-308. PubMed ID: 8280382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions.
    Hawighorst H; Knapstein PG; Schaeffer U; Knopp MV; Brix G; Hoffmann U; Zuna I; Essig M; van Kaick G
    AJR Am J Roentgenol; 1996 Feb; 166(2):401-8. PubMed ID: 8553955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [MR imaging of primary bone and soft tissue tumors].
    Uchida M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Jun; 50(6):637-48. PubMed ID: 2235314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinction between benign and malignant adrenal masses: value of T1-weighted chemical-shift MR imaging.
    Outwater EK; Siegelman ES; Radecki PD; Piccoli CW; Mitchell DG
    AJR Am J Roentgenol; 1995 Sep; 165(3):579-83. PubMed ID: 7645474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benign and malignant masses. MR imaging differentiation.
    Weatherall PT
    Magn Reson Imaging Clin N Am; 1995 Nov; 3(4):669-94. PubMed ID: 8564689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR imaging of the musculoskeletal soft tissue mass: is heterogeneity a sign of malignancy?
    Pang KK; Hughes T
    J Chin Med Assoc; 2003 Nov; 66(11):655-61. PubMed ID: 14768852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of MRS in the differentiation of benign and malignant soft tissue and bone tumors.
    Doganay S; Altinok T; Alkan A; Kahraman B; Karakas HM
    Eur J Radiol; 2011 Aug; 79(2):e33-7. PubMed ID: 21376496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MR imaging differentiation of soft-tissue hemangiomas from malignant soft-tissue masses.
    Teo EL; Strouse PJ; Hernandez RJ
    AJR Am J Roentgenol; 2000 Jun; 174(6):1623-8. PubMed ID: 10845496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
    Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
    Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating benign and malignant soft tissue masses by magnetic resonance imaging: role of tissue component analysis.
    Chen CK; Wu HT; Chiou HJ; Wei CJ; Yen CH; Chang CY; Chen WM
    J Chin Med Assoc; 2009 Apr; 72(4):194-201. PubMed ID: 19372075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Can magnetic resonance imaging differentiate between benign and malignant conditions in patients with skeletal or soft tissue tumors?].
    Lundorf E; Keller JO; Nielsen OS; Jensen OM; Christensen T
    Ugeskr Laeger; 1996 Mar; 158(11):1518-20. PubMed ID: 8644398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of computerized tomography and magnetic resonance in the assessment of benign and malignant pleural diseases].
    Falaschi F; Battolla L; Zampa V; Cioni R; Cambi L; Antonelli A; Bartolozzi C
    Radiol Med; 1996 Dec; 92(6):713-8. PubMed ID: 9122459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.